Sunday, June 16, 2013

Critical Psychology Review - 6/16/2013

Dancing with your demons - Nation on Sunday

1 Share

Dancing with your demons
Nation on Sunday
The author's contribution to action psychotherapies is an excellent critical introduction to dramatic and action therapies. Through historical analysis, theoretical discussion, and scrutiny of clinical practice, he demonstrates how creativity ...

Pathological Altruism - People's Cube (satire) (blog)

1 Share

Pathological Altruism
People's Cube (satire) (blog)
That is to say, it is largely the domain of pop psychology. "It is reasonable to wonder if the lack of ... Altruistic intentions played a critical role in the development and unfolding of the housing bubble in the United States. The same is true of the ...

Inside Business: Dog trainer uses psychology background to modify canine ... - CapitalGazette.com

1 Share

Inside Business: Dog trainer uses psychology background to modify canine ...
CapitalGazette.com
Education: B.A. in psychology from St. John's University. What I'm reading: "The Healing .....Cottman said understanding how different dogs — with different personalities — will react to various training techniques is critical to his job. While an ...

What Part Do Sleep Spindles Play In Emotional Memory: Ambien Study - RedOrbit

1 Share

RedOrbit

What Part Do Sleep Spindles Play In Emotional Memory: Ambien Study
RedOrbit
Sara C. Mednick, assistant professor of psychology at UC Riverside, along with UC San Diegopsychologists Erik. J. Kaestner and John T. Wixted, was able to determine how sleep spindles are important for emotional ... Previous research published by ... 

and more »

Love or country? Immigration law means hard choices for gay couples - CNN International

1 Share

Love or country? Immigration law means hard choices for gay couples
CNN International
There are nearly 30,000 such couples in America who now find themselves in the crosshairs of two critical national debates: the 1996 Defense of Marriage Act, or DOMA, and immigration reform. Even if Servetas were to marry Amaral in the District of ...

Annual Review of Critical Psychology 10 | CRISE 

1 Share
Acabou de ser publicado o novo número (10) da Revista de Psicologia Crítica: “Critical Psychology in a Changing World: Building Bridges and Expanding the Dialogue”. Conta com 49 artigos do mundo todo (Alemanha,...
Next Page of Stories
Loading...
Page 2

Initiative Critical Psychology: Think brain scans can reveal our ... 

1 Share
The grip of neuroscience on the academic and popular imagination is extraordinary. In recent decades, brain scientists have burst out of the laboratory into the public forum. They are everywhere, analysing and explaining ...

The Hidden Roots of Critical Psychology ... - downloaditemsr0

1 Share
The Hidden Roots of Critical Psychology: Understanding the - download ebook. Hi Guys! Sorry to be so slow in answering your questions, but here goes. If you have any questions about books feel free to ask. As usual, I will ...

Evolutionary Psychology Critical Publication (Q&A) - Modern ...

1 Share
Summarizes my critiques of evolutionary psychology and addresses critical comments.

Corrections, Psychology & Social Connection: Creating No More ... 

1 Share
Examples include the death of an offender, a re-offense in the community, or a perceived or real threat to a staff member. These types of incidents may cause critical incident stress for officers. RCMP psychologists Teal Maedel ...

'Journal of Social and Political Psychology': A New Forum for Critical ... 

1 Share
As you know, there aren't that many journals that are willing to publish critical work in psychology, so one is always intrigued by, and grateful for, any new initiatives. The recently announced Journal of Social and Political...

What The Military Is Doing To Address Its Sexual Assault Crisis

What The Military Is Doing To Address Its Sexual Assault Crisis

Chairman of the Joint Chiefs of Staff Gen. Martin Dempsey addresses Congress (Credit: AP)
Sexual assault in the military has come under heavy scrutiny in recent months after a series of scandals and a Pentagon report that estimated 26,000 cases of unwanted sexual contact in 2012, up from 19,000 in the previous year. Of the many issues that have been reported, a narrative has emerged of high and increasing rates of assault, a fear of reportingdifficulty in accessing resources, a sometimes re-traumatizing reporting and judicial process, and a misuse of powerby some commanders.
The Senate Armed Services Committee held a hearing on the crisis last week, and various pieces of legislation are being debated in both houses of Congress. As that’s occurring, the Department of Defense and the various branches of the military are also attempting to end the problem in their ranks. Here’s what each of them are — or in some cases aren’t — doing so far:

The Department of Defense

1. Re-training and re-screening of prevention and response personnel.
After officers in charge of sexual assault prevention for a Ft. Hood, TX base and the entire Air Force were accused of sexual assault, Secretary of Defense Chuck Hagel ordered the re-training, re-credentialing, and re-screening of all sexual assault prevention and response personnel. Currently, the qualifications for personnel varies across military branches, but the House recently approved a proposal that would codify and standardize selection criteria across the military. According to DoD spokeswoman Cynthia O. Smith, the DoD is in the process of standardizing selection, training, and certification standards for special victim investigators.
2. Limiting commanders’ power to overturn jury rulings.
In response to another scandal, where an Air Force colonel overturned a sexual assault conviction by blaming the victim, Hagel asked Congress to limit military commanders’ power as “convening authorities” to overturn court-martial verdicts, after a review conducted by the Pentagon in April. Commanders would still be able to change sentences, but would have to explain their reasons in writing. The Senate Armed Services Committee on Wednesdayaccepted an amendment from Sen. Claire McCaskill (D-MO) that would enact these changes.
3. Pushing back against restricting chain of command authority.
At the Senate Armed Services Committee hearing on sexual assault in the military, commanders pushed back universally against the idea of stripping decision-making power from the chain of command structure. While many advocates support the change, and Pentagon data shows that more than 25 percent of victims were assaulted by someone in their chain of command, Hagel and top commanders argued that the chain of command must be preserved to maintain order and discipline. Senate Armed Services Committee chairman Carl Levin (D-MI)sided with commanders on Wednesday by rejecting a proposal from Sen. Kirsten Gillibrand (D-NY) that would have handed cases of felony sex crimes over to independent military prosecutors outside the chain of command. Gillibrand plans to re-introduce her bill on the Senate floor.
4. Revising policies and expanding resources through the Sexual Assault Prevention and Response Office
The Department of Defense’s Sexual Assault Prevention and Response Office revised its Sexual Assault Program policy in March 2013, according to Smith, focusing on standardizing procedures and increasing training of commanders. The Office further established new standards for medical care providers and is in the process of expanding resources such as the 24-hour Safe Help Line and adding more sexual assault Resource Coordinators and Victim Advocates across branches. The Office will be charged with the DoD’s further attempts at reform in the coming months; its latest strategic plan lists prevention strategies, encouraging reporting, improved response, increased accountability, and stakeholder education as its main priorities.

The Army

5. Creating screenings and incentives for counselors and advocates.
After a two-day Sexual Harassment/Assault Prevention and Response conference, Army Secretary John McHugh issued a directive that will require behavioral health screenings for Sexual Assault Response Coordinators and Victim Advocates. The directive also triggers the creation a plan to incentive these positions through career rewards, and restricts the ability to hire these personnel to a small set of senior officers.
6. Training medical officers in evidence collection.
The Army has been developing a Sexual Assault Medical Forensics Examiners program in its South Korea base, with the goal of creating “an Army best practice model program.” Medical personnel are trained in the program to use standard evidence collection kits, and will become part of the sexual assault response process along with Response Coordinators and Victim Advocates.

The Air Force

7. Appointing a female general to head the Sexual Assault Prevention and Response Office.
After the head of the Air Force’s Sexual Assault and Prevention (SAPR) program was arrested for sexual assault, a 2-star female general was appointed to the position. Maj. Gen. Margaret Woodward plans to reorganize the office to directly report to the Air Force’s chief of staff and is seeking ideas on resolving the sexual assault crisis from outside the military. The Department of Defense’s overarching SAPR office is run by two men.
8. Creating Special Victims’ Counsels to advocate for victims.
On Monday, the Air Force opened its first dedicated facility to sexual assault response, housing newly trained lawyers from the Special Victims’ Counsel (SVC) program created earlier this year. In an attempt to tackle a problem that 85 percent of victims do not report, SVCs willadvocate solely on behalf of the victim through the entire reporting and prosecuting process. They are also charged with supporting victims in housing changes and other procedural support. Victim advocates have existed in the civilian world for many years and in the Army as Victim Advocates.

The Navy

9. Issuing a fleet-wide sexual assault awareness stand-down.
Last Wednesday, in accordance with orders from Joint Chiefs Chairman Martin Dempseydirected to all branches of the military, the Navy announced that it would be holding a three-week long Sexual Assault Awareness Stand-down in June. All personnel will be required to undergo training on basic sexual assault prevention and response principles and training from sexual assault Response Coordinators and Victim Advocates. The Navy intends for the stand-down to “refocus [its] attention” on sexual assault prevention, but it is unclear how the program will differ from previous training required of all officers. During the stand-down, the Navy will also conduct re-training of all personnel involved in sexual assault prevention. Other branches of the military are required to create plans for stand-downs by July 1.
10. Piloting “night patrol” and education programs.
The Navy is currently rolling out a pilot program in a San Diego base of 20,000 military personnel and 6,000 civilians, where a team of officers patrols the barracks charged with preventing assault. The program is based on an earlier pilot instituted in a Great Lakes base since 2011, which also included programs of targeted awareness and victim support. The program isdescribed as using bystander intervention strategies, but the concept of nighttime patrols could also overemphasize stranger rape over acquaintance rape. A Navy spokesman told ThinkProgress that since the combined programs’ establishment in the Great Lakes base in 2011, there has been a 62 percent reduction in reports of sexual assault. The next locations planned for the program’s expansion are bases in Yokosuka, Japan and Naples, Italy.

The Marines

Notably publicly absent in recent months are any specific programs from the Marine Corps, despite the Pentagon survey’s estimation that women in the Marine Corps, in 2012, faced a higher rate of sexual assault of 10.1 percent as opposed to the 6.1 percent average across the military.
Kumar Ramanathan is an intern at ThinkProgress.

The impact of the September 11 terrorist attack on suicide rates in New York City

The impact of the September 11 terrorist attack on suicide rates in New York City

Publication Abstract
Larkin, G.L., M. Tracy, and Sandro Galea. 2007. "The impact of the September 11 terrorist attack on suicide rates in New York City." Annals of Emergency Medicine, 50(3): S13-S14.
Background The literature on the impact of disasters on the rates of suicide is mixed. According to Durkheim, suicide rates should fall in the wake of external threats or crises. (Durkheim E, 1897) No studies to date have examined the impact of September 11 terrorist attacks on completed suicide in the five boroughs comprising New York City.
Study Objective
To examine the impact of 9/11 on suicide rates in New York City. Methods
An observational study using daily counts of suicides (ICD-9 Codes: E950-959) and death from undetermined injury (E960-E969) was conducted using data from the medical examiner’s office in New York City from all five boroughs: Manhattan, Queens, Brooklyn, Bronx, and Staten Island from 1994 to 2004. Confirmed suicides were analyzed with and without undetermined deaths added in order to confirm robustness of trends. Daily counts of suicide were aggregated into weekly counts from Tuesday to Monday, in order to include the week starting Tuesday, September 11, 2001. Results
Compared to 440/(661) suicides/(suicides + undetermined deaths) for the year 2001, the mean annual number of NYC suicides/(suicides plus undetermined deaths) for the years 1994-2004, 492.2/(662.8), is not significantly different (p >0.25 for both). Similarly, the mean number of suicides/(suicides plus undetermined deaths) for the month of September in the years 1994-2004, 39/(54.4), matches closely September 2001 suicides of 33/(54), respectively (p>0.25 for both). The annual fraction of suicides constituted by the month of September was 7.5% in 2001 and 7.9% on average for the years 1994-2004 (p>0..25). For the year 2001, NYC suicides plus undetermined injury deaths/month averaged 55.1 (SD=7.6), ranging from 38 to 67. The week from 9/11 to 9/17 saw 11 suicides which was not significantly different than the average of 12.6 (SD: 2.6) suicides per week both before and after 9/11 (Ptrend >0.20). Conclusion
Compared to the years, months, and weeks before and after 9/11 in the 5 boroughs of NYC, neither suicide frequencies nor suicide trajectories were significantly altered after the events of 11 September, 2001.

Psychiatrists protest against disgraced academic’s lecture at research centre

Psychiatrists protest against disgraced academic’s lecture at research centre

Posted by Xeno on June 11, 2013
Britain’s premier institute for the study of mental illness has become embroiled in a damaging row over its decision to invite a disgraced US academic to give the inaugural lecture for a new research centre.
The decision by the Institute of Psychiatry at Kings College, in central London, Europe’s largest psychiatric research organisation, to invite Professor Charles Nemeroff, an expert in the treatment of depression, has split the psychiatric profession and been attacked by members of the institute itself. Professor Nemeroff, a leading authority on the biological causes of mental illness, is one of the highest profile doctors to have been exposed for concealing large payments from pharmaceutical companies.
He was forced to resign his post at Emory University, Atlanta, in 2008 after an investigation revealed that he had failed to report more than $1.2m of payments from GlaxoSmithKline, despite having signed an undertaking to limit payments to $10,000 a year.
He received the payments whilst undertaking a study on behalf of the National Institutes of Health into drugs made by GSK.
In 2009, Professor Nemeroff was appointed chair of psychiatry at the University of Miami and was subsequently awarded a research grant of $400,000 a year for the next five years by the National Institutes of Health. In 2012 it emerged that US Senator Charles Grassley, whose 2008 investigation triggered Professor Nemeroff’s downfall, had written to the National Institutes of Health to ask why they had given him a grant when he was still under federal investigation.
Now a group of UK psychiatrists have written to the Institute of Psychiatry protesting against its decision to invite Professor Nemeroff to give the “inaugural annual lecture for the new Centre for Affective Disorders”, which is due to take place at the institute next Monday.
The group representing the radical Critical Psychiatry Network claims the Nemeroff case is frequently cited as “one of the starkest examples of the financial corruption of medicine” through its “overly cosy relationship with the pharmaceutical industry”.
“Many medical institutions have recognised this relationship is unhealthy and is bringing the profession into disrepute. We find it surprising therefore that the Institute of Psychiatry has seen fit to invite Nemeroff to deliver this important lecture,” they wrote….

Saturday, June 15, 2013

Outrage over US psychiatrist who took $1.2m from drug companies being honored in UK


Outrage over US psychiatrist who took $1.2m from drug companies being honored in UK

Professor’s invitation to give prestigious lecture in London causes outrage among peers
The Independent
By Jeremy Laurance
June 11, 2013

Disgraced psychiatrist Charles Nemeroff was exposed for failing to report more than $1.2m of payments from GlaxoSmithKline.
Britain’s premier institute for the study of mental illness has become embroiled in a damaging row over its decision to invite a disgraced US academic to give the inaugural lecture for a new research centre.
The decision by the Institute of Psychiatry at Kings College, in central London, Europe’s largest psychiatric research organisation, to invite Professor Charles Nemeroff, an expert in the treatment of depression, has split the psychiatric profession and been attacked by members of the institute itself. Professor Nemeroff, a leading authority on the biological causes of mental illness, is one of the highest profile doctors to have been exposed for concealing large payments from pharmaceutical companies.
He was forced to resign his post at Emory University, Atlanta, in 2008 after an investigation revealed that he had failed to report more than $1.2m of payments from GlaxoSmithKline, despite having signed an undertaking to limit payments to $10,000 a year.
He received the payments whilst undertaking a study on behalf of the National Institutes of Health into drugs made by GSK.
In 2009, Professor Nemeroff was appointed chair of psychiatry at the University of Miami and was subsequently awarded a research grant of $400,000 a year for the next five years by the National Institutes of Health. In 2012 it emerged that US Senator Charles Grassley, whose 2008 investigation triggered Professor Nemeroff’s  downfall, had written to the National Institutes of Health to ask why they had given him a grant when he was still under federal investigation.
Now a group of UK psychiatrists have written to the Institute of Psychiatry protesting against its decision to invite Professor Nemeroff to give the “inaugural annual lecture for the new Centre for Affective Disorders”, which is due to take place at the institute next Monday.
The group representing the radical Critical Psychiatry Network claims the Nemeroff case is frequently cited as “one of the starkest examples of the financial corruption of medicine” through its “overly cosy relationship with the pharmaceutical industry”.
“Many medical institutions have recognised this relationship is unhealthy and is bringing the profession into disrepute. We find it surprising therefore that the Institute of Psychiatry has seen fit to invite Nemeroff to deliver this important lecture,” they wrote.
Separately, Derek Summerfield, honorary senior lecturer at the Institute, wrote in the BMJ, formerly called the British Medical Journal, last week that the Institute of Psychiatry’s lauding of Professor Nemeroff as “one of the world’s leading experts” showed how psychiatric academe “sails blithely on as if such revelations beg no broader questions about its associations and supposed scientific independence.”
In a response, the Institute said it was “aware of the concerns” and took the issue of declaring financial conflicts of interest “extremely seriously”.
“We have been informed by Professor Nemeroff that he will not be presenting any research that was funded by commercial companies or affected by commercial implications. Obviously, he will be declaring any relevant conflicts of interest prior to his lecture.”
Professor Nemeroff could not be contacted for comment. He has previously said that his payments from GSK were for talks about GSK drugs now on the market, while his research funded by NIH involved basic laboratory studies of GSK chemical compounds that were years away from market.

The past, present and future of psychiatric diagnosis - by ALLEN FRANCES


PERSPECTIVE

The past, present and future of psychiatric diagnosis


ALLEN FRANCES

Department of Psychiatry, Duke University, Durham, NC, USA


Modern descriptive psychiatry was born two centuries
ago in the classification of Pinel, was later systematized in
the textbook of Kraepelin, and was then expanded by Freud
to include outpatient presentations previously seen by neurologists. Brain science also flourished in the second half of
the 19th century and has enjoyed a second revolutionary
advance during the past thirty years. Unfortunately, however, the attempt to explain psychopathology using the remarkable findings of neuroscience has thus far had no
impact on psychiatric diagnosis or treatment. The crucial
translation from basic science to clinical practice is necessarily even more difficult in psychiatry than in the rest of
medicine, because the human brain is the most complicated thing in the known universe and reveals its secrets
slowly and in small packets.
Psychiatric diagnosis must therefore still rely exclusively on fallible subjective judgments, not on objective biological tests. In the not too distant future, we will finally
have laboratory methods for diagnosing Alzheimer’s disease, but there is no pipeline of promising tests for any of
the other mental disorders. Biological findings, however
exciting, have never been robust enough to become testworthy, because the within-group variability always drowns
out the between-group differences. It appears certain that
we will be stuck with descriptive psychiatry far into the
distant future.
There have been two crises in confidence in descriptive
psychiatry: the first was in the early 1970s, the second is
occurring right now with the publication of DSM-5. The
earlier crisis was occasioned by two highly publicized
studies that exposed the inaccuracy of psychiatric diagnosis and threw into serious question the credibility of psychiatric treatment. A landmark study proved that British
and US psychiatrists came to radically different diagnostic
conclusions when viewing videotapes of the same patient
(1). And Rosenhan (2) exploded a bombshell when his
graduate students were kept in psychiatric hospitals for
extended stays after claiming to hear voices, despite the
fact that they behaved completely normally once they
were admitted. Was psychiatry entitled to a place among
medical specialties if its diagnoses were so random and its
treatments so nonspecific, especially when the other specialties were just then becoming increasingly scientific?
Psychiatry’s response was dramatic and effective. The
DSM-III, published in 1980, featured detailed definitions
of mental disorders that, when used properly, achieved reliabilities equivalent to much of medical diagnosis. The
DSM-III soon stimulated its own revolution, quickly transforming psychiatry from research stepchild to research
darling; in most medical schools, the department of psychiatry now ranks behind only internal medicine in research
funding.
But psychiatric diagnosis is now facing another serious
crisis of confidence, this time caused by diagnostic inflation. The elastic boundaries of psychiatry have been steadily expanding, because there is no bright line separating
the worried well from the mildly mentally disordered.
The DSMs have introduced many new diagnoses that
were no more than severe variants of normal behavior.
Drug companies then flexed their powerful marketing
muscle to sell psychiatric diagnoses by convincing potential patients and prescribers that expectable life problems
were really mental disorders caused by a chemical imbalance and easily curable with an expensive pill.
We are now in the midst of several market-driven diagnostic fads: attention-deficit/hyperactivity disorder (ADHD)
has tripled in rates in the past twenty years; bipolar disorder
has doubled overall, with childhood diagnosis increasing
forty-fold; and rates of autistic disorder have increased by
more than twenty-fold (3). In the US, the yearly prevalence
of a mental disorder is reported at 20–25%, with a 50% lifetime rate (4), and Europe is not far behind (5). A prospective
study of young adults in New Zealand has reported much
higher rates (6) and another of teenagers in the US found an
astounding cumulative 83% rate of mental disorders by age
21 (7).
The expanding concept of mental disorder brings with it
unfortunate unintended consequences. Only about 5% of
the general population has a severe mental disorder; the
additional 15–20% have milder and/or more temporary
conditions that are placebo responsive and often difficult
to distinguish from the expectable problems of everyday
life. Yet an amazing 20% of the US population now takes a
psychotropic drug (8) and psychotropic drugs are star revenue producers – in the US alone $18 billion/year for antipsychotics, $12 billion for antidepressants, and $8 billion
for ADHD drugs (9). And 80% of psychotropic drugs are
prescribed by primary care physicians with little training
and insufficient time to make an accurate diagnosis (10).
There are now more overdoses and deaths from prescribed
drugs than from street drugs.
And the investments in psychiatry are badly misallocated, with excessive diagnosis and treatment for many
mildly ill or essentially normal people (who may be more
harmed than helped by it), and relative neglect of those
with clear psychiatric illness (whose access to care in the
US has been sharply reduced by slashed mental health
budgets) (11). It is no accident that only one third of
111people with severe depression get any mental health care
or that a large percentage of the swollen US prison population consists of psychiatric patients with no place else to
go (12). A recent meta-analysis shows the results of psychiatric treatment to equal or surpass those of most medical specialties (13), but the treatments must be delivered
to those who really need them, not squandered on those
likely to do as well or better on their own.
This disparity between treatment need and treatment
delivery is about to get much worse. The DSM-5 has introduced several new disorders at the fuzzy and populous border with normal and has also loosened requirements for
many of the existing disorders. The biggest problems are
removing the bereavement exclusion for major depressive
disorder, adding a very loosely defined somatic symptom
disorder, reducing the threshold for adult ADHD and posttraumatic stress disorder, adding a diagnosis for temper
tantrums, introducing the concept of behavioral addictions,
combining substance abuse with substance dependence,
and adding mild neurocognitive disorder and binge eating
disorder.
The DSM-5 has been prepared without adequate consideration of clinical risk/benefit ratios and has not calculated the large economic cost of expanding the reach of
psychiatry. It has been unresponsive to the widespread
professional, public, and press opposition that was based
on the opinion that its changes lacked sufficient scientific
support and often defied clinical common sense. And
a petition endorsed by fifty mental health associations
for an independent scientific review, using methods of
evidence based medicine, was ignored.
There will be no sudden paradigm shift replacing descriptive psychiatry with a basic explanatory understanding of the pathogeneses of the different mental disorders.
This will be the gradual and painstaking work of many
decades. In the meantime, we must optimally use the
tools of descriptive psychiatry to ensure reliable and
accurate diagnosis and effective, safe, and necessary
treatment. It is time for a fresh look. The preparation
of the ICD-11 provides an opportunity to re-evaluate
psychiatric diagnosis and to provide cautions against its
over-inclusiveness.
References
1. Kendell RE, Cooper JE, Gourlay AJ et al. Diagnostic criteria of
American and British psychiatrists. Arch Gen Psychiatry 1971;
25:123-30.
2. Rosenhan DL. On being sane in insane places. Science 1973;179:
250-8.
3. Batstra L, Hadders-Algra M, Nieweg EH et al. Child emotional
and behavioral problems: reducing overdiagnosis without risking
undertreatment. Dev Med Child Neurol 2012;54:492-4.
4. Kessler RC, Berglund P, Demler O et al. Lifetime prevalence and
age-of-onset distributions of DSM-IV disorders in the National
Comorbidity Survey Replication. Arch Gen Psychiatry 2005;6:593-
602.
5. de Graaf R, ten Have M, van Gool C et al. Prevalence of mental
disorders and trends from 1996 to 2009. Results from the Netherlands Mental Health Survey and Incidence Study-2. Soc Psychiatry Psychiatr Epidemiol 2012;47:203-13.
6. Moffitt TE, Caspi A, Taylor A et al. How common are common
mental disorders? Evidence that lifetime prevalence rates are
doubled by prospective versus retrospective ascertainment. Psychol Med 2010;40:899-909.
7. Copeland W, Shanahan L, Costello EJ et al. Cumulative prevalence of psychiatric disorders by young adulthood: a prospective
cohort analysis from the Great Smokey Mountains Study. J Am
Acad Child Adolesc Psychiatry 2011;50:252-61.
8. Medco Health Solutions Inc. America’s state of mind. www.
medco.com.
9. IMS Institute for Healthcare Informatics. The use of medicines in
the United States: review of 2011. www.imshealth.com.
10. Mark TL, Levit KR, Buck JA. Datapoints: psychotropic drug prescriptions by medical specialty. Psychiatr Serv 2009;60:1167.
11. Wang PS, Aguilar-Gaxiola S, Alonso J et al. Use of mental health
services for anxiety, mood, and substance disorders in 17 countries in the WHO World Mental Health Surveys. Lancet 2007;
370:841-50.
12. Fuller Torrey E. Out of the shadows: confronting America’s mental illness crisis. New York: Wiley, 1997.
13. Leucht S, Hierl S, Kissling W et al. Putting the efficacy of psychiatric and general medicine medication into perspective: review of
meta-analyses. Br J Psychiatry 2012;200:97-106.
DOI 10.1002/wps.20027

Down the wrong path: Book details psychiatry's lack of objective science

Public release date: 12-Jun-2013
Print | E-mail Share Share Close Window ] 

Contact: Tomi Gomory
tgomory@fsu.edu
850-644-2328
Florida State University 

Down the wrong path: Book details psychiatry's lack of objective science

 IMAGE: This is Tomi Gomory, an associate professor in the Florida State University College of Social Work.
Click here for more information.
TALLAHASSEE, Fla. — Psychiatry — which uses well-intentioned coercion, unscientific diagnoses and psychoactive drugs that do as much harm as good — is a science that is off course, according to a new book co-written by Tomi Gomory, an associate professor in the Florida State University College of Social Work.
In "Mad Science: Psychiatric Coercion, Diagnosis and Drugs" (2013, Transaction Publishers), Gomory and co-authors Stuart A. Kirk of the University of California-Los Angeles and David Cohen of Florida International University discuss several keys points that the international psychiatric community is beginning to wrestle with, including the description of troubling human behaviors as medical diseases.
"No one doubts that people have strange behaviors, but how you explain those behaviors is important because strange behaviors are not necessarily medical diseases or the result of them," Gomory said. "This is where psychiatry has gone down the wrong path."
"Mad Science" is the most comprehensive of five recently published, scholarly books that take a critical look at the notion of medical psychiatry and the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM), the bible of psychiatry. Even the National Institute of Mental Health criticizes the DSM for its lack of objective laboratory measures, Gomory said.
Gomory and his co-authors base their claims on eight years of reviewing mainstream research and analyzing the history of madness and psychiatry as well as the language of psychiatry. In the final chapter, they envision a "nonmedicalized" future of helping the seriously emotionally troubled members of society.
The scientific character of medical diseases includes physiological lesions or signs as well as more subjective symptoms or patient complaints. Psychiatric "diseases" have no lesions or physical markers.
"There isn't any science behind labels such as schizophrenia, bipolar disorder, post-traumatic stress disorder or any of the more than 300 mental illnesses that the DSM psychiatric work groups have created," Gomory said. "They are merely arbitrary conceptual categories with no legitimate medical science to back them up."
Gomory points to brain lesions, which are the identifiable biological markers of an overwhelming number of neurological diseases. Yet there are no such markers for any of the behaviors that psychiatry describes as a disease or mental disorder.
"We argue that simply labeling troubling human behavior as a brain disease is not the answer," Gomory said. "Neurology is the medical profession that handles brain diseases, so anything that is a legitimate brain disease should be identified and treated through neurology, not psychiatry."
When it comes to using psychotropic drugs to treat troubling human behaviors as if they were medical diseases, psychiatry has proceeded on uncritically accepted claims, rather than well-tested evidence.
"Psychiatric drugs are not a panacea by any means," Gomory said. "Many of these drugs are black-labeled by the Federal Drug Administration, which is its most serious warning. In many cases, the things you think they should decrease they increase for many people."
Antidepressants, the latest of which are known as selective serotonin reuptake inhibitors or SSRIs, are habit forming, can increase anxiety or make people suicidal. Antipsychotics, which suppress central nervous system activity, are used to manage very disturbing behavior. They can lead to serious weight gain, diabetes and heart disease and can cause various neurological disorders including tardive dyskinesia, a permanent, physically disfiguring movement disorder.
"These are more than casual side-effects, but serious, adverse conditions in themselves," he said.
When it comes to solving behavior that is strange, absurd or frightening, Gomory says that society should work within psychological, social, ethical and moral parameters rather than medical parameters, and never rely on coercive measures such as forced institutionalization.
"There is no science to back up the validity of psychiatric coercion, essentially locking people up or forcing them to take medication, because the literature is clear we can neither predict or prevent serious self-harming behaviors," Gomory said.
People with strange behavior who don't want help and are not harming others or themselves should be left alone, according to Gomory.
"If someone is hearing voices and they find that is a problem, then you help them," Gomory said. "Others might consider the voice to be a benign companion, like the imaginary friends of young children. We should not make helping a coercive activity, but we should offer to help anyone who wants help using the strong evidence base available for psychosocial treatment approaches for troubled or troubling behaviors."


###